CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers and degenerative diseases in Malaysia and Singapore. Its lead product candidate is CTM-N2D, an expanded gamma delta T cells grafted with natural killer group 2D ligands-targeting chimeric antigen receptor, which is in Phase I clinical trials comprising to improve anti-cancer cytotoxicity. The company is also developing iPSC-gdNKT, a plu...
Oct 2, 2025, 12:02 PM EDT - 4 weeks ago
Oct 2, 2025, 7:00 AM EDT - 4 weeks ago
Aug 28, 2025, 9:00 AM EDT - 2 months ago
Aug 18, 2025, 9:00 PM EDT - 2 months ago
Jul 21, 2025, 10:01 AM EDT - 3 months ago
Apr 28, 2025, 4:05 PM EDT - 6 months ago
Feb 6, 2025, 7:20 AM EST - 9 months ago
Jan 6, 2025, 11:10 AM EST - 10 months ago
Aug 20, 2024, 7:00 AM EDT - 1 year ago
CIA CVKD ELUT EUDA GOSS GOVX IMRN
Jul 17, 2024, 7:00 AM EDT - 1 year ago
Mar 20, 2024, 8:30 AM EDT - 1 year ago
Mar 18, 2024, 6:00 AM EDT - 1 year ago
Mar 4, 2024, 5:00 AM EST - 1 year ago
Jan 29, 2024, 7:00 AM EST - 1 year ago
Dec 5, 2023, 7:30 AM EST - 2 years ago
Nov 17, 2023, 9:21 AM EST - 2 years ago
Nov 14, 2023, 7:47 AM EST - 2 years ago
Oct 24, 2023, 1:00 PM EDT - 2 years ago
Sep 25, 2023, 7:00 AM EDT - 2 years ago
Sep 1, 2023, 8:00 PM EDT - 2 years ago
Aug 29, 2023, 9:00 AM EDT - 2 years ago
Aug 20, 2023, 3:50 AM EDT - 2 years ago
ARQT SMMT
Aug 17, 2023, 7:30 AM EDT - 2 years ago
Aug 15, 2023, 1:00 PM EDT - 2 years ago
Aug 1, 2023, 7:00 AM EDT - 2 years ago
Jul 27, 2023, 9:00 AM EDT - 2 years ago
Jul 6, 2023, 7:00 AM EDT - 2 years ago
May 11, 2023, 9:00 AM EDT - 2 years ago
May 9, 2023, 10:07 AM EDT - 2 years ago
Apr 13, 2023, 8:00 PM EDT - 2 years ago
Apr 7, 2023, 5:30 AM EDT - 2 years ago
ARBB ATMU GDHG GMM ISPR KVUE MGIH
Feb 3, 2023, 5:46 PM EST - 2 years ago